A neutrality index identifies mox-YG as a minimally cytotoxic protein, enabling ultra-high expression and uncovering key physiological consequences of protein burden.

The Illumina Protein Prep rollout boosts multiomics, strengthens disease insights and supports ILMN stock momentum.

WASHINGTON and ZURICH, May 19, 2025 (GLOBE NEWSWIRE) -- SISCAPA Assay Technologies, a global leader in high-sensitivity protein quantitation, and Biognosys, a pioneer in next-generation proteomics, ...

Thermo Fisher Scientific is rolling out a research test to profile dozens of proteins linked to neurodegenerative ...

As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...

Cerillo, pioneer in compact microplate reader technology, is proud to announce the launch of Rayo, its newest multiwavelength ...

Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease ...

When confirming antibody concentrations, sizing up proteins, or seeking the perfect formulation for a next-gen biologic, traditional approaches leave researchers tied to the lab bench for way too long ...

Tension has been brewing in the world of nutrition. The subject of the dispute? Protein — or more precisely, protein requirements, and journalists, scientists, government officials, and health ...